Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Baker

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 7, 2015
Diffusion MRI properties of the human uncinate fasciculus correlate with the ability to learn visual associationsCibu Thomas, Alexandru Avram, Carlo Pierpaoli, et al.
The Australasian Journal of Dermatology|September 17, 2015
Five-year experience with infliximab: Follow up of the product familiarisation programRebecca Nguyen, Anna Braue, Chris Baker, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
Biological Therapy Interruption and Re-Treatment in Chronic Plaque PsoriasisCharlie Yue Wang, Peter Foley, Chris Baker, et al.
Cureus|February 14, 2022
Caseous Calcification: Now You See Me, Now You Don'tJoel Thekekara, Jack Xu, Chris Baker, et al.
The Australasian Journal of Dermatology|July 18, 2002
Late-onset warfarin necrosisCatherine E Scarff, Chris Baker, Prue Hill, et al.
The Australasian Journal of Dermatology|April 17, 2024
Dupilumab for chronic actinic dermatitis: A case series and review of the literatureZachary Holmes, Peter Foley, Chris Baker, et al.
Journal of Child Neurology|May 25, 2002
Valproate-associated stomatitisMelody Ryan, Robert J Baumann, Craig S Miller, et al.
The Australasian Journal of Dermatology|April 22, 2020
Infliximab drug survival in chronic plaque psoriasis: follow-up of the product familiarisation programWilliam Berry, Benjamin Daniel, Rebecca Nguyen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 6, 2009
LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteinsHeather Basciano, Abigale Miller, Chris Baker, et al.
The Australasian Journal of Dermatology|February 8, 2025
Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant DiseaseZachary Holmes, Conor Larney, Peter Foley, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 7, 2015
Diffusion MRI properties of the human uncinate fasciculus correlate with the ability to learn visual associationsCibu Thomas, Alexandru Avram, Carlo Pierpaoli, et al.
The Australasian Journal of Dermatology|September 17, 2015
Five-year experience with infliximab: Follow up of the product familiarisation programRebecca Nguyen, Anna Braue, Chris Baker, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
Biological Therapy Interruption and Re-Treatment in Chronic Plaque PsoriasisCharlie Yue Wang, Peter Foley, Chris Baker, et al.
Cureus|February 14, 2022
Caseous Calcification: Now You See Me, Now You Don'tJoel Thekekara, Jack Xu, Chris Baker, et al.
The Australasian Journal of Dermatology|July 18, 2002
Late-onset warfarin necrosisCatherine E Scarff, Chris Baker, Prue Hill, et al.
The Australasian Journal of Dermatology|April 17, 2024
Dupilumab for chronic actinic dermatitis: A case series and review of the literatureZachary Holmes, Peter Foley, Chris Baker, et al.
Journal of Child Neurology|May 25, 2002
Valproate-associated stomatitisMelody Ryan, Robert J Baumann, Craig S Miller, et al.
The Australasian Journal of Dermatology|April 22, 2020
Infliximab drug survival in chronic plaque psoriasis: follow-up of the product familiarisation programWilliam Berry, Benjamin Daniel, Rebecca Nguyen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 6, 2009
LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteinsHeather Basciano, Abigale Miller, Chris Baker, et al.
The Australasian Journal of Dermatology|February 8, 2025
Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant DiseaseZachary Holmes, Conor Larney, Peter Foley, et al.
Pageof 7